Highlights
Home-grown research attracts high investor interest
Home-grown, high-tech health research from the Maurice Wilkins Centre has attracted support from local and international inve...
read the full story
Using 'molecular superglue' to build protein trees
Biological batteries, new vaccines and more cost-effective pharmaceuticals are just some of the potential benefits of Maurice...
read the full story
Cells get increasing coverage
Human cells have always been important in Maurice Wilkins Centre research, but new developments open up new ground for both r...
read the full story
Re-thinking the causes of rheumatic fever
Researchers and health professionals are re-thinking the causes of rheumatic fever after studies by Maurice Wilkins Centre in...
read the full story
Chemistry, bio and immunology combine to target immune receptor
A Maurice Wilkins Centre collaboration across several scientific disciplines has led to a patent for a new immunotherapy drug...
read the full story
Newly funded research highlights MWC collaborations
A five-year research programme aims to develop nontoxic vaccine technologies to complement existing cancer immunotherapies.
read the full story
The tumour-promoting activities of a famous protein
Developing new cancer therapies and a more reliable test for prostate cancer are just some of the potential outcomes of Mauri...
read the full story
New insight into an established diabetes target
Facilitating the development of better medicines for diabetes, obesity and cardiovascular disease is a key driver behind some...
read the full story
Early career researchers zoom in on an important drug target
An estimated 1.3 million people die from tuberculosis (TB) each year, and new drugs are desperately needed, especially as res...
read the full story
Standouts on the science stage
In 2016, Maurice Wilkins Centre investigators received a number of national and international honours in recognition of their...
read the full story